Group 1 - The core point of the article is that UBTECH's logistics subsidiary, Youqi, has successfully completed the first batch of PVT vehicles for its autonomous logistics vehicle, Chitu α, at Foxconn's new energy vehicle R&D center in Zhengzhou [1] - The PVT phase is a critical verification stage for vehicle mass production delivery capability, focusing on manufacturing consistency, process stability, and quality traceability under mass production conditions [1] - The production process at Foxconn's automotive-grade intelligent manufacturing system covers the complete closed loop of vehicle assembly, testing, and delivery, laying a solid foundation for the next phase of Chitu α's mass production ramp-up and bulk delivery [1]

Group 1 - iQOO launched its new gaming smartphone iQOO15Ultra with a starting price of 4999 yuan after national subsidies, featuring a custom ice dome cooling system [1] - The iQOO15Ultra is equipped with the fifth-generation Snapdragon 8 flagship processor and incorporates multiple cooling structures and materials, including an aviation aluminum heat dissipation channel and a large VC uniform heat dissipation plate [1] - The increasing performance of mobile devices necessitates advanced cooling solutions, as passive heat dissipation methods are insufficient, leading to the adoption of active cooling components like fans in smartphones [1] Group 2 - According to Guotou Securities, the application of micro fans in smartphones is on the rise, with several companies in the supply chain making clear advancements in this area [2] - The trend towards active cooling solutions in smartphones is expected to accelerate, marking a shift towards an era of active cooling in the industry [2]

Group 1 - The company plans to repurchase shares using 1 to 2 billion yuan of its own funds, with a minimum of 700 million yuan and a maximum of 1.4 billion yuan for A-shares, and a minimum of 300 million yuan and a maximum of 600 million yuan for B-shares [1][2] - The repurchase is part of the company's strategic layout, aiming to achieve cumulative sales of 40 million vehicles by 2028 and an annual production and sales target of 5 million vehicles by 2030, positioning itself among the top ten global automotive brands [1] - The company expects its new energy vehicle sales to reach 1.109 million units by 2025, representing a year-on-year growth of 51.1%, and plans to launch 26 new products over the next three years, covering over 140 countries and regions [1] Group 2 - The repurchase reflects the company's confidence in its strategic outlook and intrinsic value, aiming to protect company value and shareholder rights, while addressing long-standing concerns about B-share liquidity [2] - In January, the company delivered 170,831 vehicles globally, with notable sales from the CS75 series and the Eado series, and significant contributions from its new energy segment [2] - The repurchase is expected to enhance earnings per share (EPS) and return on equity (ROE) by reducing share capital [2]

转自：中国证券报·中证网 中证报中证网讯（记者 王婧涵）2月5日，记者从三维天地获悉，日前三维天地与大连理工大学签署 《S-tab软件授权合作意向书》。双方将围绕数据分析人才的培养、国产统计分析软件普及与高等教育 数字化转型展开深度合作，共同构建产学研用一体化的教育新生态。三维天地表示，此次合作立足于资 源共享与优势互补，旨在推动国产软件在高校教学科研中的广泛应用。 四是建立长期合作机制，以技术赋能教育。三维天地表示，公司与大连理工大学的合作，将以S-tab软 件为纽带，共同探索数字化转型背景下数据分析教学的新模式，培育兼具国际视野与自主创新能力的高 素质人才。 一是深化产学研融合，共促学术科研创新。双方将围绕"学术交流"展开多层次互动。定期组织讲座、论 坛及研讨会，共享质量管理、六西格玛及数据分析领域的前沿成果，促进研究人员知识体系的持续更新 与技能提升。 双方将依托各自在理论研究与应用开发方面的优势，联合申报并开展面向产业需求的科 研项目，涵盖基础研究、应用开发及技术创新等多个维度，推动学术成果向现实生产力的高效转化。 二是推动赛教融通，助力实践型人才培养。合作将重点聚焦于学生实践能力与创新素养的提升。大 ...

中证报中证网讯(记者罗京)据"西子洁能"官微，近日，杭州市具身智能机器人产业链对接会在西子洁能 旗下的西子智慧产业园举行。会上，西子洁能宣布拟作为有限合伙人参与设立产业基金，聚焦人工智 能、具身智能及AIDC数据中心能源技术等前沿领域，通过产投联动推动技术创新与产业升级。基金由 禧筠资本创始合伙人汤筠负责运作。 上述负责人进一步表示，园区内人形机器人将开展多场景应用探索：在消费场景中从事送餐、引导、保 洁等工作；在工厂车间参与精细化生产操作；在写字楼与公寓区域承担巡逻、快递搬运、清洁等工作。 未来园区还将规划学研、赛训及机器人4S维保场景，构建"研发-测试-生产-应用-维修"全周期产业生 态。 值得关注的是，浙江人形机器人赛训基地由杭州市上城区人民政府、中移(杭州)信息技术有限公司、浙 江人形机器人创新中心有限公司、北京北奥集团有限责任公司、西子洁能、浙江浪潮通信有限公司六方 联合签约共建。各方将以"政产学研用"协同模式为核心，推动基地实现"实训、研发、赛事、应用"四位 一体的功能定位。 西子洁能相关负责人表示，依托完善的场景生态、精准的资本布局与高效的政企协同，西子洁能正以持 续开放的场景资源、专业赋能的产 ...

Core Viewpoint - China Pacific Insurance (601601) is launching a new strategic initiative focused on "AI+" to reshape the insurance value chain, emphasizing proactive risk management, enhanced service experience, and collaborative productivity [1][2] Group 1: Strategic Initiatives - The company has officially initiated three major strategies: "Health and Wellness," "Internationalization," and "AI+" [1] - The "AI+" strategy is identified as the core force for transforming the insurance value chain [1] Group 2: Key Focus Areas - The first focus area is to reshape risk management from a reactive to a proactive approach, transitioning from "post-compensation" to "pre-risk control and in-process reduction" [1] - The second focus area aims to enhance service experience by ensuring technology delivers a brand promise of being "by your side" at every service moment [1] - The third focus area involves transforming productivity and organizational collaboration through pilot "AI-native subsidiaries," moving from "human-driven" to "human-machine collaboration" [1] Group 3: Digital Transformation - The chairman emphasized that digital transformation is not optional but a necessity for survival and development [1] - The implementation of the "AI+" strategy will involve strong leadership, dynamic assessment, and a commitment to genuine digital transformation rather than superficial changes [1] Group 4: Collaborative Ecosystem - At the conference, China Pacific Insurance announced collaborations with Tencent Cloud, iFlytek (002230), Huawei, Baidu Cloud, and Alibaba Cloud to showcase advancements in various AI applications [2] - The company aims to leverage AI technology as a core engine to shift from traditional compensation models to proactive risk management, fostering a new open and symbiotic insurance technology ecosystem [2]

面向未来，齐鲁银行表示，将继续聚焦高质量发展核心主线，深化改革转型与数字化赋能，夯实客户基 础与风控体系，在服务区域发展中实现自身成长，为股东、客户与社会创造可持续价值。 中证报中证网讯(记者张鹏飞)2月4日，齐鲁银行（601665）披露2025年业绩快报。该行坚持稳中求进总 基调，交出了一份量质双升的答卷，资产规模、归母净利润实现双位数增长，资产质量连续7年持续改 善。 在业绩稳步增长的同时，齐鲁银行积极践行股东回报承诺，宣布将于2月11日实施派息计划。2025年12 月，该行推出2025年度中期分红方案，拟向全体股东每10股派发现金红利1.21元，总计派发7.45亿元， 占2025年半年度归母普通股股东净利润的28.48%。自上市以来，齐鲁银行现金分红总额逐年提升，彰 显了其稳健持续的盈利能力，也展现出该行与股东共享发展成果、回馈投资者信任的坚定承诺。 快报显示，截至2025年末，齐鲁银行总资产突破8000亿元大关，达到8043.81亿元，较上年末增长 16.65%；贷款总额3828.34亿元，存款总额4895.31亿元，分别同比增长13.55%和11.37%。此外，齐鲁银 行经营效益稳步提升，2025年 ...

中证报中证网讯(记者石诗语)近日，国家金融监督管理总局网站显示，江苏金融监管局核准张斌、李健 江苏农商联合银行副行长的任职资格。 据了解，江苏农商联合银行由江苏省农村信用社联合社改制组建。2025年3月，江苏农商联合银行获批 开业，注册资本为77亿元。彼时，监管部门核准胡建斌任该行董事长、尹立鸿任该行行长。从股东构成 看，江苏省财政厅出资50亿元，持股50亿股，持股比例64.935%，为江苏农商联合银行第一大股东；江 苏凤凰出版传媒集团有限公司、江苏省港口集团有限公司均出资10亿元，持股10亿股，持股比例均为 12.987%；江苏省环保集团有限公司、江苏省产权交易所有限公司分别出资5亿元、2亿元，持股比例分 别为6.494%、2.597%。 ...

建设银行表示，本次签约有利于强化供给与需求匹配、租赁与购置联动，将推动上海住房保障体系更加 完善，进一步拓宽房源筹措渠道，缩短建设周期，优化区域布局，助力形成"政策引导、市场运作、多 方协同、群众得益"的良好格局。建设银行将制定专项方案，从融资安排、资金监管、个人住房按 揭、"科创E建行"科技人才一站式服务平台等方面，为项目推进提供全周期、多层次的金融服务。 中证报中证网讯（记者 石诗语）日前，建设银行（601939）举办支持上海市首批收购二手住房用于保 障性租赁住房项目签约活动。建设银行上海市分行相关支行与上海市浦东新区、静安区、徐汇区三个区 公租房公司签署合作协议。首批拟收购房精准匹配各领域人才"职住平衡"需求，为更多青年人提供优质 居住选择。 ...

Core Viewpoint - The company, Zhifei Biological Products (300122), has received clinical trial approval for two vaccines developed by its wholly-owned subsidiary, Zhifei Longkema, indicating a continuous expansion of its vaccine research pipeline [1] Group 1: Vaccine Approvals - On February 3, the company announced the approval of its mRNA vaccine for shingles, which is a product based on its proprietary mRNA technology, marking the first mRNA vaccine approved for clinical trials in China [1] - The shingles mRNA vaccine is noted for its good immunogenicity and high safety profile, effectively preventing the occurrence of shingles [1] - On February 4, the company announced the approval of its lyophilized inactivated varicella vaccine, which utilizes an innovative inactivation technology and is suitable for individuals aged 12 months and older [1] Group 2: Safety and Target Population - The varicella vaccine is designed to provide a safer option for both healthy individuals and those with immune deficiencies or contraindications for vaccination [1] - The company emphasizes that vaccine development involves significant investment, long cycles, and high risks, with uncertainties regarding the clinical trial progress, results, and subsequent approval for production and commercialization [1] Group 3: Financial Impact - The company indicates that the clinical trials for the two vaccines will not have a significant impact on its recent financial performance and will continue to fulfill its information disclosure obligations as required [1]